"We're obviously very gratified by these results," said Dr. Hassan. "Based on the findings of our clinical trial, we expect that obstetricians and clinicians will begin to consider providing expectant mothers with ultrasound screening for cervical length, and to make progesterone therapy available to those who present with a short cervix.
"Our group has been working on this approach to reducing infant mortality for much of the past decade, and it's very exciting to see that the effort is paying off, and that mothers and infants will soon be able to benefit from it."
"As a research university, Wayne State's mission is to discover and apply knowledge that contributes to the positive development and well being of society," said Valerie M. Parisi, M.D., M.P.H., M.B.A., Dean of the WSU School of Medicine. "Today's findings are an example of research that is quickly translated into improved clinical care outcomes. Wayne State will aggressively share this new knowledge with health care providers here in Detroit, in Michigan and around the world so that it can benefit pregnant women. I'm confident that the strong partnership between the PRB, the DMC and Wayne State will continue to result in pioneering contributions for pregnant women and unborn children."
|Contact: Julie O'Connor|
Wayne State University - Office of the Vice President for Research